Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off ...

Eli Lilly and Novo Nordisk are expected to price their new obesity pills in line with existing injections, as analysts cite ...

Howard Marks dissects market madness, separating price from value, and warns investors: fundamentals are fading while ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.65, with a ...

Trump's flip-flopping on Intel highlights the impact of politics on investor sentiment. New leadership, government investment ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.56, along ...

Nvidia's China woes have major implications for tech ETFs as Beijing pressures firms to use domestic alternatives. Near-term ...

The Social Security Administration recently announced the addition of 13 conditions to its Compassionate Allowances list, a ...

Needham analyst initiates AeroVironment at Buy with a $300 target, citing drone market growth, BlueHalo deal and rising ...

Wyoming has become the first U.S. public entity to issue a blockchain-based stablecoin, launching the Frontier Stable Token ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

EV demand weakens as Trump's rollback of tax credit and automakers' price cuts weigh on the industry. Ford shifts strategy ...